KN046 in Subjects With Advanced Squamous Non-small Cell Lung Cancer

Summary

This study is a randomized, double-blind, multicenter, phase III clinical study to compare the clinical efficacy and safety of KN046 plus paclitaxel and carboplatin versus placebo plus paclitaxel and carboplatin in subjects with advanced squamous NSCLC who have not previously received systemic treatment.

Timeline

Start

2020-09-14

Primary completion

2022-08-30

Completion

2023-08-30

Drugs

Indications